About
Dr. Gøril Rolfseng Grøntvedt is a clinical researcher at the JCA and KISN at NTNU. Her work focuses on improving the clinical diagnosis and understanding of Alzheimer’s disease, with particular emphasis on early detection and biomarker development.
Research Interests
- Clinical presentation and diagnosis of AD
- Development and validation of biomarkers
- Early detection of cognitive decline
- Implementation of innovative diagnostic tools
Recent Research
Her current research focuses on developing and validating enhanced clinical protocols for early detection of Alzheimer’s disease. She works on integrating novel biomarkers with traditional clinical assessments to improve diagnostic accuracy and enable earlier intervention.
Selected Publications
- Gonzalez-Ortiz, F., Kirsebom, B.-E., Contador, J., Tanley, J.E., Selnes, P., Gísladóttir, B., Pålhaugen, L., Suhr Hemminghyth, M., Jarholm, J., Skogseth, R., Bråthen, G., Grøndtvedt, G., Bjørnerud, A., Tecelao, S., Waterloo, K., Aarsland, D., Fernández-Lebrero, A., García-Escobar, G., Navalpotro-Gómez, I., Turton, M., Hesthamar, A., Kac, P.R., Nilsson, J., Luchsinger, J., Hayden, K.M., Harrison, P., Puig-Pijoan, A., Zetterberg, H., Hughes, T.M., Suárez-Calvet, M., Karikari, T.K., Fladby, T., Blennow, K., 2024. Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease. Nat Commun 15, 2908. https://doi.org/10.1038/s41467-024-47286-5
- Grøntvedt, G.R., Sando, S.B., Lauridsen, C., Bråthen, G., White, L.R., Salvesen, Ø., Aarsland, D., Hessen, E., Fladby, T., Waterloo, K., Scheffler, K., 2022. Association of Klotho Protein Levels and KL-VS Heterozygosity With Alzheimer Disease and Amyloid and Tau Burden. JAMA Netw Open 5, e2243232. https://doi.org/10.1001/jamanetworkopen.2022.43232
- Grøntvedt, G.R., Schröder, T.N., Sando, S.B., White, L., Bråthen, G., Doeller, C.F., 2018. Alzheimer’s disease. Current Biology 28, R645–R649. https://doi.org/10.1016/j.cub.2018.04.080